3SBio Inc. (OTCMKTS:TRSBF) Stock Short Interest Report for September

3SBio Inc. (OTCMKTS:TRSBF) saw a significant decrease in short interest in the month of September. As of September 30th, there was short interest totaling 8,190,396 shares, a decrease of 40.6% from the September 15th total of 13,790,396 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

3SBio Stock Performance

Shares of OTCMKTS TRSBF opened at $1.90 on Friday. The company has a 50 day simple moving average of $2.12 and a 200 day simple moving average of $2.35. 3SBio has a 1 year low of $1.90 and a 1 year high of $4.74.

3SBio Company Profile

3SBio Inc is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of biologic medicines. Its operations center on therapies for oncology, nephrology, autoimmune disorders and other serious or chronic diseases.

The company’s portfolio includes recombinant protein products such as EPIAO, a recombinant human erythropoietin used to treat anemia, and TPIAO, a thymosin alpha-1 product used in immune-related treatment settings. 3SBio also develops and markets other biologic therapies, including products based on monoclonal antibodies and tumor necrosis factor inhibitors, as well as medicines for supportive care and specialty treatment areas.

Founded in 1993, 3SBio has built research, manufacturing and commercial operations in China and serves the domestic pharmaceutical market through hospitals, healthcare providers and distribution partners.